Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials von Al-Sawaf, O., Robrecht, S., Bahlo, J., Fink, A. M., Cramer, P., v Tresckow, J., Lange, E., Kiehl, M., Dreyling, M., Ritgen, M., Dürig, J., Tausch, E., Schneider, C., Stilgenbauer, S., Wendtner, C. M., Fischer, K., Goede, Hallek, M., Eichhorst, B.

Volltext

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma von Mai, E K, Bertsch, U, Dürig, J, Kunz, C, Haenel, M, Blau, I W, Munder, M, Jauch, A, Schurich, B, Hielscher, T, Merz, M, Huegle-Doerr, B, Seckinger, A, Hose, D, Hillengass, J, Raab, M S, Neben, K, Lindemann, H-W, Zeis, M, Gerecke, C, Schmidt-Wolf, I G H, Weisel, K, Scheid, C, Salwender, H, Goldschmidt, H

Volltext

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia von Nückel, H, Switala, M, Sellmann, L, Horn, P A, Dürig, J, Dührsen, U, Küppers, R, Grosse-Wilde, H, Rebmann, V

Volltext

Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling von Oberbeck, S., Schrader, A., Warner, K., Jungherz, D., Crispatzu, G., von Jan, J., Chmielewski, M., Ianevski, A., Diebner, H.H., Mayer, P., Kondo Ados, A., Wahnschaffe, L., Braun, T., Müller, T.A., Wagle, P., Bouska, A., Neumann, T., Pützer, S., Varghese, L., Pflug, N., Thelen, M., Makalowski, J., Riet, N., Göx, H.J.M., Rappl, G., Altmüller, J., Kotrová, M., Persigehl, T., Hopfinger, G., Hansmann, M.L., Schlößer, H., Stilgenbauer, S., Dürig, J., Mougiakakos, D., von Bergwelt-Baildon, M., Roeder, I., Hartmann, S., Hallek, M., Moriggl, R., Brüggemann, M., Aittokallio, T., Iqbal, J., Newrzela, S., Abken, H., Herling, M.

Volltext

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia von Dürig, J, Dührsen, U, Klein-Hitpass, L, Worm, J, Hansen, J B Rode, Ørum, H, Wissenbach, M

Volltext

Ibrutinib + bortezomib + R‐CHOP for higher‐risk DLBCL: Feasibility, efficacy and molecular predictors von Denker, S., Bittner, A., Frick, M., Kase, J., Hoffmann, J., Trenker, C., Keller, U., Bogner, C., Hüttmann, A., Dürig, J., Janz, M., Mathas, S., Marks, R., Krohn, U., Na, I., Bhattacharya, A., Hübner, N., Akalin, A., Bullinger, L., Schmitt, C. A.

Volltext

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells von Manteniotis, S, Wojcik, S, Göthert, J R, Dürig, J, Dührsen, U, Gisselmann, G, Hatt, H

Volltext

Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial von Huhn, S, Weinhold, N, Nickel, J, Pritsch, M, Hielscher, T, Hummel, M, Bertsch, U, Huegle-Doerr, B, Vogel, M, Angermund, R, Hänel, M, Salwender, H J, Weisel, K, Dürig, J, Görner, M, Kirchner, H, Peter, N, Graeven, U, Lordick, F, Hoffmann, M, Reimer, P, Blau, I W, Jauch, A, Dembowsky, K, Möhler, T, Wuchter, P, Goldschmidt, H

Volltext

Human Cord Blood B Cells Differ from the Adult Counterpart by Conserved Ig Repertoires and Accelerated Response Dynamics von Budeus, Bettina, Kibler, Artur, Brauser, Martina, Homp, Ekaterina, Bronischewski, Kevin, Ross, J. Alexander, Gorgens, Andre, Weniger, Marc A., Dunst, Josefine, Kreslavsky, Taras, da Conceicao Castro, Symone Vitoriano, Murke, Florian, Oakes, Christopher C., Rusch, Peter, Andrikos, Dimitrios, Kern, Peter, Koeninger, Angela, Lindemann, Monika, Johansson, Patricia, Hansen, Wiebke, Lundell, Anna-Carin, Rudin, Anna, Duerig, Jan, Giebel, Bernd, Hoffmann, Daniel, Kueppers, Ralf, Seifert, Marc

Volltext

HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE FOLLICULAR LYMPHOMA: INITIAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3) von Herfarth, K., Scholz, C. W., Hübel, K., Wirths, S., Buske, C., Dürig, J., Forstpointner, R., Heidegger, S., Lenz, G., König, L., Meißner, J., Höller, U., Baues, C., De‐Colle, C., Wiegel, T., Gauler, T., Li, M., Combs, S. E., Eich, H., Sander, A., Mavriopuoluo, E., Kieser, M., Pott, C., Dreyling, M.

Volltext

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia von DÜRIG, J, NÜCKEL, H, CREMER, M, FÜHRER, A, HALFMEYER, K, FANDREY, J, MÖRÖY, T, KLEIN-HITPASS, L, DÜHRSEN, U

Volltext

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia von SCHROERS, R, GRIESINGER, F, TRÜMPER, L, HAASE, D, KULLE, B, KLEIN-HITPASS, L, SELLMANN, L, DÜHRSEN, U, DÜRIG, J

Volltext

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important... von DÜRIG, J, BUG, S, KLEIN-HITPASS, L, BOES, T, JÖNS, T, MARTIN-SUBERO, J. I, HARDER, L, BAUDIS, M, DÜHRSEN, U, SIEBERT, R

Volltext

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia von DÜRIG, J, NASCHAR, M, SCHMÜCKER, U, RENZING-KÖHLER, K, HÖLTER, T, HÜTTMANN, A, DÜHRSEN, U

Volltext

P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA von Huhn, S., Poos, A. M., Mai, E. K., Hänel, M., Salwender, H. J., Dürig, J., Blau, I. W., Scheid, C., Weisel, K. C., Munder, M., Berlanga, O., Bertsch, U., Goldschmidt, H., Weinhold, N.

Volltext

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status von HÜTTMANN, A, KLEIN-HITPASS, L, DÜHRSEN, U, DÜRIG, J, THOMALE, J, DEENEN, R, CARPINTEIRO, A, NÜCKEL, H, EBELING, P, FÜHRER, A, EDELMANN, J, SELLMANN, L

Volltext

UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT von Egle, A., Jäger, U., Skrabs, C., Dürig, J., Nösslinger, T., Wanner, D., Steurer, M., Ringshausen, I., Melchardt, T., Greil, R., Ysebaert, L.

Volltext

Differential expression of chemokine receptors in B cell malignancies von Duhrsen, U, Durig, J, Schmucker, U

Volltext

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells von Edelmann, J, Klein-Hitpass, L, Carpinteiro, A, Führer, A, Sellmann, L, Stilgenbauer, S, Dührsen, U, Dürig, J

Volltext

P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY‐DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH‐RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO... von Mai, E. K., Bertsch, U., Fenk, R., Tichy, D., Besemer, B., Dürig, J., Schroers, R., Metzler, I., Hänel, M., Mann, C., Asemissen, A. M., Heilmeier, B., Nievergall, E., Huhn, S., Kriegsmann, K., Weinhold, N., Luntz, S., Holderrried, T. A. W., Trautmann‐Grill, K., Gezer, D., Klaiber‐Hakimi, M., Müller, M., Khandanpour, C., Knauf, W., Scheid, C., Munder, M., Geer, T., Riesenberg, H., Thomalla, J., Hoffmann, M., Raab, M. S., Salwender, H. J., Weisel, K. C., Goldschmidt, H.

Volltext